Cargando…

Extremely late stent thrombosis after more than 7 years (2691 days) of sirolimus-eluting stent implantation

Detalles Bibliográficos
Autores principales:	Demirci, Deniz, Demirci, Dugu Ersan, Arslan, Şakir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998849/ https://www.ncbi.nlm.nih.gov/pubmed/29537973 http://dx.doi.org/10.14744/AnatolJCardiol.2018.57983

Ejemplares similares

Simultaneous subacute thrombosis in two new-generation drug-eluting stents in different vessels
por: Demirci, Duygu Ersan, et al.
Publicado: (2018)

Late Thrombosis of Sirolimus-Eluting Stent: A Multifactorial Problem
por: Kranjec, Igor, et al.
Publicado: (2009)

Very Late Stent Thrombosis 42 Months after Implantation of Sirolimus-Eluting Stent and Discontinuation of Antiplatelet Therapy
por: Sibbing, Dirk, et al.
Publicado: (2009)

Multiple Sequential Complications After Sirolimus-Eluting Stent Implantation: Very Late Stent Thrombosis, Stent Fracture, In-Stent Restenosis, and Peri-Stent Aneurysm
por: Seol, Sang-Hoon, et al.
Publicado: (2009)

Extensive Late-Acquired Incomplete Stent Apposition After Sirolimus-Eluting Stent Implantation
por: Choi, Hyun-Chul, et al.
Publicado: (2010)

A Case of Stent Thrombosis Occurred at 5 Years after Sirolimus-Eluting Stent Implantation
por: Kim, Su A, et al.
Publicado: (2011)

Extremely Late In-Stent Thrombosis 12 Years After Implantation of a Drug-Eluting Stent
por: Sleiman, Elsa, et al.
Publicado: (2020)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021)

Sirolimus-eluting coronary stents: a review
por: Abizaid, Alexandre
Publicado: (2007)

Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
por: Kim, Byeong-Keuk, et al.
Publicado: (2010)

Pathogenesis of late in-stent thrombosis after treatment with drug-eluting stents
por: Hao, Hiroyuki
Publicado: (2012)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Very Late Stent Thrombosis of Sirolimus-eluting Stent 59 Months After Implantation: A First Report from The Middle-East and Review of Literature
por: Panduranga, Prashanth, et al.
Publicado: (2011)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents
por: Velders, Matthijs A., et al.
Publicado: (2013)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
por: Jafaripour, Iraj, et al.
Publicado: (2023)

Acute two-vessel occlusion due to simultaneous very late stent thrombosis following sirolimus-eluting stent implantation: a case report and review of the literature
por: Sang, Zhenchi, et al.
Publicado: (2015)

Correction: Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents
por: Velders, Matthijs A., et al.
Publicado: (2013)

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
por: Kakizaki, Ryota, et al.
Publicado: (2020)

Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
por: Sharma, Raghav, et al.
Publicado: (2022)

Association of Localized Hypersensitivity and In-Stent Neoatherosclerosis with the Very Late Drug-Eluting Stent Thrombosis
por: Yamaji, Kyohei, et al.
Publicado: (2014)

Long-term effectiveness and safety of sirolimus drug-eluting stents
por: Bikkina, Mahesh, et al.
Publicado: (2011)

Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Reduction of In-Stent Restenosis and Inflammation with One Stent: New Concept of Sirolimus and Ascorbic Acid-Eluting Coronary Stent
por: Ryu, JiWung, et al.
Publicado: (2021)

Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents
por: Kim, J-S, et al.
Publicado: (2009)

Acute stent thrombosis in a sirolimus eluting stent after wasp sting causing acute myocardial infarction: a case report
por: Greif, Martin, et al.
Publicado: (2009)

Early definite stent thrombosis with everolimus-eluting stents
por: Naito, Ryo, et al.
Publicado: (2015)

The different features of angiographic peri‐stent contrast staining after implantation of sirolimus‐eluting stents
por: Kageyama, Michiya, et al.
Publicado: (2017)

Very Late Stent Thrombosis due to Neointimal Rupture After Paclitaxel-Eluting Stent Implantation
por: Kee, Won Ju, et al.
Publicado: (2011)

Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement
por: Otsuka, Fumiyuki, et al.
Publicado: (2012)

Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent
por: Improta, Riccardo, et al.
Publicado: (2021)

Is There Any Significant Difference in Stent Thrombosis Between Sirolimus and Paclitaxel Eluting Stents?: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)

Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes
por: Zhang, Haijun, et al.
Publicado: (2016)

Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Vascular Responses to First-Generation Sirolimus-Eluting Stents and Bare-Metal Stents Beyond 10 Years
por: Hada, Masahiro, et al.
Publicado: (2021)

Myocardial bridging is a potential risk factor of very late stent thrombosis of drug eluting stent
por: Jiang, Qixia, et al.
Publicado: (2012)

Kounis Syndrome Presenting as Very Late Stent Thrombosis in an Everolimus-Eluting Stent Following Wasp Stings
por: Min, Jung Hwa, et al.
Publicado: (2013)

Biodegradable polymer-coated thin strut sirolimus-eluting stent versus durable polymer-coated everolimus-eluting stent in the diabetic population
por: Gasior, Pawel, et al.
Publicado: (2021)

Sirolimus-Eluting Stents vs Uncoated Stents for the Treatment of Proximal Left Anterior Descending Coronary Artery Stenosis
por: Valencia, José, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_7cqeudchg602lcrai2n7lv618b